Individuals with Hepatic Impairment Ritalin has not been studied in patients with hepatic impairment. Hepatic impairment is predicted to have minimal impact on the pharmacokinetics of methylphenidate as it is metabolized principally to ritalinic acid by nonmicrosomal hydrolytic esterases that happen to be extensively distributed through the physiqu